Margo Marrone Reacquires The Organic Pharmacy From Istituto Ganassini

Margo Marrone has bought back The Organic Pharmacy, six years after selling the organic and natural beauty brand to Italian pharmaceutical group Istituto Ganassini in 2018 to secure its future growth.

The reacquisition returns the British brand — built on a founding philosophy of health, detoxification and lifestyle — to the founder who created it. Ganassini's family owners will remain involved as a distribution partner in Italy, while refocusing their wider business on other brands within the pharmaceutical industry.

For trade buyers and retail partners, the change of control resets the ownership structure of a brand that has spent a decade inside an Italian pharma group, and repositions it as a founder-led operation with distribution continuity in one of its key European markets.

What does the change mean for the brand's direction?

The company framed the buy-back as a significant new chapter, reconnecting The Organic Pharmacy with its founding philosophy and reinforcing the relationship between skin health, internal wellbeing and healthy ageing. Marrone's return arrives, in the company's words, at a time when "holistic health, preventative wellness and longevity are increasingly central to the global wellness conversation."

"It was incredibly emotional to return to The Organic Pharmacy, and I feel so grateful to be back," said Marrone. "I am really looking forward to getting creative again and exploring what comes next for the brand."

That language signals a product-development agenda set once again by the founder rather than by a corporate parent. Formulators and buyers tracking the brand should expect the emphasis on toxin-free positioning and professional client advice — the pillars Marrone built the business on — to guide the pipeline.

"The Organic Pharmacy was the realisation of my dream: to bring under one roof professional client advice, an exceptional, personal service that enables me to form a bond with my clients, and the best products in the world that are free from toxins," Marrone added.

Where does the formulation pipeline stand?

The brand has not stood still on product. It recently broke into the retinal category with the launch of Retinal Renewal Night Serum, which The Organic Pharmacy claims helps diminish pigmentation and reinforce the skin barrier during sleep.

The retinal launch matters for two professional audiences. For treatment providers, it adds a vitamin A option to a menu that has historically leaned on the brand's detoxification and holistic positioning. For buyers, it signals willingness to compete in the crowded night-serum segment, where retinaldehyde formulations increasingly serve clients who want retinoid results with a gentler tolerability profile.

What happens next?

Ganassini's continued role as Italian distributor preserves supply continuity in that market while the group redirects resources toward its other pharmaceutical brands. The open question for the trade is how quickly Marrone deploys her renewed creative control: the next data points to watch are the first post-acquisition product launches and any expansion of the retinal line under founder ownership.